All News


ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration appointed Frank M. Torti, M.D., M.P.H, as principal deputy commissioner and chief scientist. Torti's appointment with FDA will begin in May.

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration issued a final guidance last week regarding investigational new drug applications for human gene therapy.

ePT--the Electronic Newsletter of Pharmaceutical Technology

In an ongoing effort to secure the safety of prescription drugs, the US Food and Drug Administration has released its draft five-year plan under the Prescription Drug User Fee Act (PDUFA).

ePT--the Electronic Newsletter of Pharmaceutical Technology

Senator Chuck Grassley (R-IA) sent a letter to Amgen (Thousand Oaks, CA) last week asking the company to account for the high rebates it has given to certain physician groups who bought Aranesp.

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration withdrew a direct final rule that changed current good manufacturing practice (CGMP) regulations for finished pharmaceuticals. The agency withdrew the rule because it received significant adverse comments from industry.

ePT--the Electronic Newsletter of Pharmaceutical Technology

The deadline for the implementation of California's prescription drug tracking system, ePedigree, has been delayed until January 2011.

i1-505458-1408663315409.jpg

Although there have been recent setbacks for China with regard to exported products, the country has made substantial strides in its pharmaceutical industry over the past few years. Intense competition and a series of new regulations seem to be moving the country into a period of recovery.

i1-505362-1408663435917.jpg

Antibodies are highly specific molecules that can be tailored to recognize almost any stretch of peptide that nature can conjure: a feature that has been exploited for years now to produce therapeutic antibodies.